Skip to content

Transition From Donor Milk: a Feasibility Study

Transition From Donor Milk: a Feasibility Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06514014
Enrollment
20
Registered
2024-07-23
Start date
2025-05-01
Completion date
2027-06-30
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth, Nutrition, Healthy

Keywords

newborn, human milk

Brief summary

Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.

Interventions

DIETARY_SUPPLEMENTPreterm Infant Formula

Transition from donor human milk to preterm infant formula

Sponsors

Augusta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Open Label Randomized Clinical Trial

Eligibility

Sex/Gender
ALL
Age
28 Days to No maximum
Healthy volunteers
No

Inclusion criteria

1. Greater than 1,250 grams 2. At least 28 days of life 3. Diet consisting of donor human milk with/without mother's own milk

Exclusion criteria

1. Birth weight below the 5th percentile 2. History of necrotizing enterocolitis, spontaneous intestinal perforation, or other gastrointestinal disorder 3. Congenital anomalies 4. Care team discretion

Design outcomes

Primary

MeasureTime frameDescription
Weight Velocity36 weeks post menstrual ageWeight velocity between birth and 36 weeks post menstrual age
Fat free mass36 weeks post menstrual ageFat free mass at 36 weeks post menstrual age

Secondary

MeasureTime frame
Number of Patients with Bronchopulmonary dysplasia36 weeks post menstrual age
Number of Patients with Retinopathy of prematurity36 weeks post menstrual age
Number of Patients with Sepsis36 weeks post menstrual age
Number of Patients with Necrotizing enterocolitis36 weeks post menstrual age

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026